p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP)
Antonio Travaglino(University of Insubria), Luigi Insabato(Federico II University Hospital), Domenico Alessandro Oliviero(Ospedale Maggiore), Rosa Maria Alfano(University of Milan), Fulvio Zullo(Magna Graecia University), Annarita Gencarelli(University of Naples Federico II), Antonio Raffone(University of Campania "Luigi Vanvitelli"), Daniele Neola(University of Naples Federico II), Antonio Mollo(Northwestern University), Maria Raffaela Campanino(University of Naples Federico II), Federica Cariati(University of Naples Federico II)
Cited by 23
Related Papers
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|328
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|281
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
|The Journal of Clinical Endocrinology & Metabolism|2004|276
The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263
The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|254